Hollis-Eden Pharmaceuticals Responds To Sources Sought Notice From Department Of Defense For Acute Radiation Syndrome Therapy For U.S. Forces

SAN DIEGO--(BUSINESS WIRE)--Jan. 31, 2006--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced that it has responded to the Sources Sought Notice (SSN) from the Department of Defense (DOD) titled, "Seeking Sources in the Advanced Development of Medical Radiation Countermeasures." This response was due January 31, 2006. The Company has also received a letter from the DOD indicating that it intends to issue a Request for Proposal (RFP) for medical radiation countermeasures in the first half of 2006 and that it highly encourages Hollis-Eden to respond to the RFP once issued. The SSN is the first step in this procurement process.